UAE Becomes Second Country to Approve Oral GLP-1 Pill - How Pharmacy-Led Distribution Is Redefining the Active Lifestyle Supplement Market

The UAE supplement aisle looks nothing like it did even two years ago. In February 2026, nutraceutical distributor NutraONE placed the country's broader wellness market at approximately USD 4 billion, a company estimate reported by Gulf News rather than an independently audited figure, but one that signals how large the addressable opportunity has become. The UAE is also the first market outside the United States to approve the oral Wegovy weight-management pill, doctors and dietitians are cautioning younger consumers against using protein shakes as meal replacements, and the drug regulator is actively pulling underperforming supplements off shelves. Distribution, product development, capital, and oversight are all moving at once.

There is currently no sufficiently transparent, independently verifiable estimate for the UAE active lifestyle supplements market specifically, covering sports nutrition, general wellness, and weight management as one category. Published nutraceutical and wellness-sector figures vary widely depending on whether they include only dietary supplements or extend to functional foods, beverages, and weight-management products. What the developments of 2026 demonstrate, however, is that the shift is structural, reshaping consumer behaviour, product development, medical oversight, distribution, regulation, and investment, rather than reflecting a short-lived wellness trend.

Market Highlights

• GLP-1 milestone - oral Wegovy approved by the Emirates Drug Establishment on June 1, 2026, making the UAE the second country globally, after the United States, to approve the oral formulation.

• Fitness participation - Dubai Fitness Challenge drew 3 million-plus participants in 2025, up from roughly 2.7 million in 2024, with 16 million-plus cumulative participants since 2017.

• Regulatory tightening - the Emirates Drug Establishment recalled three dietary supplements and one medical product in February 2026 alone, citing contamination and unauthorised ingredients.

• Global benchmark - Makreo Research's Global Active Lifestyle Supplement Market and Forecast to 2030 recorded a global CAGR of approximately 8.01% between 2021 and 2025, with online channels holding approximately 37% of global market value in 2025.

A Widening Consumer Base Beyond Traditional Gym Culture

Active lifestyle supplements in the UAE were long sold on a narrow premise: athletes and regular gym users needed protein and recovery products, while everyone else was a secondary audience. That premise has broken down.

Dubai's flagship 30x30 initiative, the Dubai Fitness Challenge, drew more than 3 million participants in its 2025 edition, up from roughly 2.7 million in 2024, and has engaged over 16 million participants since launching in 2017. Its tenth edition runs October 31 to November 29, 2026.

Participation in a public fitness programme does not translate directly into supplement sales. It does signal that active living is becoming embedded across families, office workers, recreational exercisers, and older residents, not just established fitness communities. Makreo Research's global study reflects this by segmenting the category into athletes and bodybuilders, recreational fitness users, fitness-conscious consumers, and active-ageing and wellness-focused consumers, covering sports supplements, general health and wellness products, weight-management supplements, and other functional categories.

GLP-1 Approval Creates a New Nutrition Category

The most significant structural shift in the UAE market is not a new protein format, but the mainstream arrival of GLP-1 weight-management medication.

On June 1, 2026, the Emirates Drug Establishment approved oral Wegovy (semaglutide) for long-term weight management and cardiovascular-risk reduction in eligible adults, making the UAE the second country after the United States to approve the oral formulation. Demand through hospitals, clinics, and virtual-health platforms has been rising, though the total UAE user base has not been officially published, so individual platform registrations should be read as directional interest rather than a national figure. UAE clinicians have cautioned that GLP-1 medication requires proper screening, dosing, and follow-up care rather than casual use.

That gap between rapid consumer adoption and the need for clinical oversight is opening space for GLP-1 companion nutrition: products designed to support nutritional needs when appetite and food intake fall, typically featuring concentrated protein, fibre, hydration and electrolyte support, and smaller nutrient-dense servings. These are positioned to support supervised weight-management programmes, not to substitute for medication or treat any medical condition.

The clinical infrastructure is catching up alongside the nutrition category. In February 2026, Metabolic, the Dubai-based parent of GluCare.Health and Zone.Health, closed a strategic growth capital facility with RAKBANK to scale its continuous, data-driven approach to metabolic care, including GLP-1-supported weight management through Zone.Health. The company cites the economic impact of overweight and obesity in the UAE at an estimated USD 11.67 billion, underlining why outcomes-accountable, technology-enabled care models are attracting institutional capital alongside consumer-facing nutrition products.

Danone's Oikos Fusion, a smaller-format cultured dairy drink with whey protein, leucine, vitamin D, and prebiotic fibre, illustrates how global manufacturers are building for this consumer, separate from Danone's core protein-shake range. UAE-specific GLP-1 companion ranges remain limited today, which points to a positioning opportunity that still needs validation on user profile, preferred formats, pharmacy and clinician acceptance, permitted claims, and pricing before entry.

Protein Culture Is Colliding With Clinical Pushback

The UAE's protein boom, driven by gym culture, influencer marketing, and easy online purchasing, has extended well beyond athletes into daily use by Millennials, Gen Z, and even teenagers. UAE dietitians, including those from Aster Clinic and NMC Speciality Hospital, are pushing back on the idea that more protein automatically improves health or training outcomes, and have flagged particular concern about adolescents using shakes as routine meal replacements without an assessed nutritional need.

The concern is not that protein shakes are unsafe. Used appropriately, for post-training recovery, delayed meals, or professionally assessed higher protein needs, they add value. The risk is when a supplement product regularly replaces balanced meals. Products that succeed here are likely to be those with transparent serving guidance, full ingredient disclosure, and clear usage claims, rather than aggressive transformation messaging.

Distribution Is Consolidating Around Pharmacy and Marketplace Channels

How UAE consumers buy supplements is also shifting. In February 2026, wellness distributor NutraONE announced an exclusive distribution partnership with Nutrifactor Laboratories across the UAE, Saudi Arabia, Turkey, the UK, and Canada, prioritising the UAE and Saudi Arabia first with more than 100 SKUs spanning weight management, muscle health, sports nutrition, and other wellness categories. The model pairs pharmacy-led, goal-based positioning with planned expansion onto marketplaces such as Amazon and Noon.

This combination responds to a real decision-fatigue problem: as product choice and health claims multiply, consumers want more guidance. Pharmacies offer credibility, trained staff, and confidence in product authenticity; marketplaces offer convenience, price comparison, and reviews. One partnership does not make pharmacy-plus-marketplace the dominant UAE model on its own; supermarkets, specialist nutrition stores, gym-led retail, and direct-to-consumer channels remain relevant depending on the product and audience.

Makreo's global report supports a multi-channel view, covering supermarkets and hypermarkets, online platforms, specialty nutrition and fitness stores, pharmacies and drug stores, and other convenience channels. Online channels held approximately 37% of global active lifestyle supplement market value in 2025, underlining the weight of digital distribution in this category.

Personalisation and Longevity Are Becoming Part of the Product Itself

UAE-linked capital and product launches are moving beyond ingestible supplements into performance technology, AI-driven formulation, and precision nutrition.

• BioAro -in February 2026, the Canadian-linked biotechnology company secured UAE regulatory approval for its BioActive Longevity Stack, comprising Longevity+, CellOmega+, and CreaGen, following earlier approvals in the United States and the United Kingdom. The formulations were developed using an AI-enabled research platform and are age- and sex-specific, positioning the UAE as BioAro's Middle East hub and reflecting a shift from single-ingredient formulas toward multi-component, systems-oriented stacks.

• Nu Skin - in April 2026, the company launched Prysm iO, an AI-powered device that scans a fingertip in approximately 15 seconds to generate a personalised antioxidant and nutritional-wellness score. The platform debuted in the United States and is expected to expand into additional international markets.

• Bioniq - the AI-driven personalised-supplement company reported that its global member base grew more than fivefold following Cristiano Ronaldo's 2024 investment. It has identified the Middle East, alongside the United States and Europe, as a priority expansion region. A current UAE-specific growth figure was not independently verifiable, but the company's regional focus reflects growing demand for personalised wellness platforms across the Gulf.

• Herbalife and Bioniq (M&A) - Herbalife moved to acquire Bioniq's core personalised-nutrition business, strengthening its presence in data-led and customised supplementation.

• Unilever and Grüns (M&A) - Unilever's acquisition of greens-supplement brand Grüns expanded its exposure to convenient, digitally distributed wellness products.

Global Capital and Infrastructure Are Backing the UAE's Wellness Momentum

Deal activity and event infrastructure confirm that global and regional players see the UAE's active lifestyle and nutraceutical space as investable, not just interesting.

FMCG majors are building UAE legal entities, not just export relationships. Zydus Wellness International DMCC, the UAE holding arm of India's Zydus Wellness, incorporated two step-down subsidiaries in Dubai in June 2026: Zydus Wellness Trading L.L.C. on June 24, and Zydus Wellness General Trading DWC-LLC on June 30, each capitalised at AED 300,000. Both are intended to strengthen Middle East distribution across food and nutrition products, vitamins, minerals, supplements, nutraceuticals, and personal care, and neither has commenced operations yet, signalling a longer-term commitment to building local operating infrastructure rather than a near-term revenue event.

UAE-linked capital is also moving into performance technology. WHOOP, the human-performance wearable company, raised USD 575 million at a USD 10.1 billion valuation, with Mubadala and 2PointZero Group among the investors, highlighting the UAE's growing interest in technologies that connect biometric data, training, recovery, and nutrition.

On the care-delivery side, Metabolic's growth capital facility with RAKBANK, closed in February 2026, is funding a third UAE flagship site at Dubai Digital Park alongside new centres in London and the United States, an example of a Dubai-headquartered, technology-enabled care model being exported outward rather than imported, a reversal of the region's traditional role as a consumer of foreign healthcare models.

Industry infrastructure is also arriving. Vitafoods Middle East and Africa, part of Informa Markets' nutraceutical events portfolio alongside Vitafoods Europe, Asia, and India, will hold its inaugural edition at the Dubai World Trade Centre on September 22 and 23, 2026. Vitafoods' own visitor research found that 46% of attendees at its existing events either currently operate in, or are planning to operate in, the Middle East, underscoring the region's pull for ingredient suppliers, contract manufacturers, and finished-product brands.

How Makreo Research Supports Market Entry Decisions

These developments raise practical questions for brands: how large is the addressable opportunity, which segment to enter first, what format to launch, which channel to prioritise, and what compliance timeline to plan around.

• Strategy and Corporate Planning teams weighing GLP-1 companion nutrition against general wellness or conventional sports nutrition can use bespoke research to map competitor concentration and entry opportunities.

• R&D, Product Development, and Packaging teams navigating the shift to the Emirates Drug Establishment can validate formulation, claims, labelling, packaging formats, and registration requirements ahead of a launch timeline.

• Retail and Distribution teams comparing pharmacy-led versus marketplace- or specialist-store-led entry can use market surveys to assess demand, pricing sensitivity, and channel preference directly with UAE shoppers and trade partners.

• Marketing and Sales teams moving past protein-first messaging can pressure-test recovery, active-ageing, weight-management, and GLP-1-support claims before launch.

For the wider structural picture, Makreo Research's Global Active Lifestyle Supplement Market and Forecast to 2030 provides global context for this article. The study covers sports supplements, general health and wellness, weight management, and other categories, across powders, capsules and tablets, liquids, and other formats, by distribution channel, end user, and geography, with the Middle East and Africa assessed as a distinct regional segment across 2021 to 2030. The global market recorded a CAGR of approximately 8.01% between 2021 and 2025, with online channels holding approximately 37% of global value in 2025.

It is worth reiterating that this report provides global and regional context, not a separately published UAE market value. The UAE-specific developments covered here draw on regulatory announcements, company disclosures, and local reporting, interpreted for their commercial implications.

Makreo Research and Consulting provides global market intelligence reports, custom research, and consumer market surveys across the global nutraceutical, functional food, and health and wellness sectors. To discuss your market entry, expansion strategy, or competitive benchmarking needs, contact us at [email protected].

Frequently Asked Questions

How big is the UAE's active lifestyle supplement market in 2026?

There is no single, independently verified figure for the UAE active lifestyle supplement market specifically. Distributor NutraONE cited the broader UAE nutraceutical and wellness market at approximately USD 4 billion in February 2026. Growth indicators include rising fitness participation, GLP-1 companion nutrition, expanding pharmacy and e-commerce distribution, and new local entities from global wellness companies.

What is GLP-1 companion nutrition, and why does it matter in the UAE?

GLP-1 companion nutrition supports people using prescribed GLP-1 weight-management medication, typically through concentrated protein, fibre, hydration, and micronutrient support for reduced food intake. It is gaining relevance following the June 2026 approval of oral Wegovy and the rise of continuous metabolic-care platforms such as Zone.Health. These products should never claim to replace medication or treat obesity.

Which distribution channels are growing fastest for UAE supplements?

Pharmacies and online marketplaces are gaining share, combining consumer trust with accessibility and delivery convenience, as shown by the NutraONE-Nutrifactor rollout onto Amazon and Noon. They are not yet the dominant channel overall; supermarkets, specialist stores, and direct-to-consumer channels remain relevant depending on product and audience.